Nitric oxide in critical respiratory failure of very low birth weight infants

Paediatric Respiratory Reviews

Volumn 5, Issue SUPPL. A, 2004, Pages

  Hallman, Mikko ^a   Aikio, Outi ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; INDUCIBLE NITRIC OXIDE SYNTHASE; LUNG SURFACTANT; NITRIC OXIDE; PORACTANT; SCAVENGER; VASODILATOR AGENT; FREE RADICAL; OXYGEN;

ARTICLE; CHRONIC LUNG DISEASE; CLINICAL TRIAL; CRITICAL ILLNESS; DRUG EFFICACY; DRUG MECHANISM; DRUG OXIDATION; FETUS DISEASE; GAS EXCHANGE; HUMAN; IMMUNE SYSTEM; LUNG INFECTION; NEWBORN; PERINATAL PERIOD; PNEUMONIA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY FAILURE; SURVIVAL RATE; VERY LOW BIRTH WEIGHT; ANTIOXIDANT ACTIVITY; BLEEDING; DISEASE SEVERITY; DRUG SELECTIVITY; LIPID SOLUBILITY; LUNG INJURY; METHEMOGLOBINEMIA; NEWBORN MORTALITY; OUTCOMES RESEARCH; OXIDATION; PATENT DUCTUS ARTERIOSUS; PREMATURE FETUS MEMBRANE RUPTURE; REVIEW;

EID: 1342291276     PISSN: 15260542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1526-0542(04)90047-4     Document Type: Review

References (21)

1. Kinsella JP, Walsh WF, Bose CL, Gerstmann DR, Labella JJ, Sardesai S, et al. Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomized controlled trial. Lancet 1999; 354: 1061-1065.
2. The Franco-Belgium Collaborative NO Trial Group. Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomized controlled trial. Lancet 1999; 354: 1066-1071.
3. Saugstad OD. Inhaled nitric oxide for preterm infants - still an experimental therapy. Lancet 1999; 354: 1047-1048.
4. Hallman M, Bry K. Nitric oxide and lung surfactant. Semin Perinatol 1996; 20: 173-185.
5. Gaston B, Drazen JM, Loscalzo J, Stamler JS. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med 1994; 149: 538-551.
6. Bredt DS, Snyder SH. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 1994; 63: 175-195.
7. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996; 271: C1424-C1437.
8. Halbower AC, Tuder RM, Franklin WA, Pollock JS, Forstermann U, Abman SH. Maturation-related changes in endothelial nitric oxide synthase immunolocalization in developing ovine lung. Am J Physiol 1994; 267: L585-L591.
9. Storme L, Rairigh RL, Parker TA, Kinsella JP, Abman SH. In vivo evidence for a myogenic response in the fetal pulmonary circulation. Pediatr Res 1999; 45: 425-431.
10. Le Cras TD, Markham NE, Morris KG, Ahrens CR, McMurtry IF, Abman SH. Neonatal dexamethasone treatment increases the risk for pulmonary hypertension in adult rats. Am J Physiol Lung Cell Mol Physiol 2000; 278: L822-L829.
11. Jakkula M, Le Gras TD, Gebb S, Hirth KP, Tuder RM, Voelker NF, Abman SH. Inhibition of angiogenesis decreases alveolarization in the developing lung. Am J Physiol Lung Cell Mol Physiol 2000; 279: L600-L607.
12. Harju K, Glumoff V, Hallman M. Ontogeny of Toll-like receptors Tlr2 and Tlr4 in mice. Pediatr Res 2001; 49: 81-83.
13. Beckman J, Beckman T, Chen J, Marshall P, Freeman B. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-1624.
14. Banks BA, Ischiropoulos H, McClelland M, Ballard PL, Ballard RA. Plasma 3-nitrotyrosine is elevated in premature infants who develop bronchopulmonary dysplasia. Pediatrics 1998; 101: 870-874.
15. Haddad IY, Ischiropoulos H, Holm BA, Beckman JS, Baker JR, Matalon S. Mechanisms of peroxynitrite-induced injury to pulmonary surfactants. Am J Physiol 1993; 265: L555-L564.
16. O'Donnell VB, Freeman BA. Interactions between nitric oxide and lipid oxidation pathways: implications for vascular disease. Circ Res 2001; 88: 12-21.
17. Gutierrez HH, Nieves B, Chumley P, Rivera A, Freeman BA. Nitric oxide regulation of superoxide-dependent lung injury: oxidant-protective actions of endogenously produced and exogenously administered nitric oxide. Free Radic Biol Med 1996; 21: 43-52.
18. Issa A, Lappalainen U, Kleinman M, Bry K, Hallman M. Inhaled nitric oxide decreases hyperoxia-induced surfactant abnormality in preterm rabbits. Pediatr Res 1999; 45: 247-254.
19. Kinsella JP, Ivy DD, Abman SH. Ontogeny of NO activity and response to inhaled NO in the developing ovine pulmonary circulation. Am J Physiol 1994; 267: H1955-H1961.
20. Aikio O, Vuopala K, Pokela ML, Hallman M. Diminished inducible nitric oxide synthase expression in fulminant early-onset neonatal pneumonia. Pediatrics 2000; 105: 1013-1019.
21. Aikio O, Saarela T, Pokela ML, Hallman M. Nitric oxide treatment and acute pulmonary inflammatory response in very premature infants with intractable respiratory failure shortly after birth. Acta Pediatr 2003; 92: 65-69.